These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 273863)

  • 1. Uric acid metabolism in therapy of glycogen storage disease type I.
    Benke PJ; Gold S
    Pediatr Res; 1978 Mar; 12(3):204-6. PubMed ID: 273863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen storage disease type 1: impact of medium-chain triglycerides on metabolic control and growth.
    Das AM; Lücke T; Meyer U; Hartmann H; Illsinger S
    Ann Nutr Metab; 2010; 56(3):225-32. PubMed ID: 20357432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diet and growth of children with glycogen storage disease Types I and III.
    Daeschel IE; Janick LS; Kramish MJ; Coleman RA
    J Am Diet Assoc; 1983 Aug; 83(2):135-41. PubMed ID: 6409953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of hyperuricemia in glycogen storage disease, type I.
    Roe TF; Kogut MD
    Pediatr Res; 1977 May; 11(5):664-9. PubMed ID: 266162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP depletion, a possible role in the pathogenesis of hyperuricemia in glycogen storage disease type I.
    Greene HL; Wilson FA; Hefferan P; Terry AB; Moran JR; Slonim AE; Claus TH; Burr IM
    J Clin Invest; 1978 Aug; 62(2):321-8. PubMed ID: 276529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nocturnal intragastric glucose infusion in the treatment of glycogenosis 1].
    Pronicka E; Pieniazek D; Rowecka K; Miłoszewska E; Gruszczyńska B; Celińska D; Szymański W; Goncerzewicz M
    Pediatr Pol; 1982; 57(7-8):579-83. PubMed ID: 6963394
    [No Abstract]   [Full Text] [Related]  

  • 7. Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease.
    Greene HL; Slonim AE; O'Neill JA; Burr IM
    N Engl J Med; 1976 Feb; 294(8):423-5. PubMed ID: 813144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III.
    Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):383-90. PubMed ID: 19073362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dietary treatment of children with type I glycogen storage disease with slow release carbohydrate.
    Smit GP; Berger R; Potasnick R; Moses SW; Fernandes J
    Pediatr Res; 1984 Sep; 18(9):879-81. PubMed ID: 6384910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary metabolic changes in von Gierke's disease (Type I glycogen storage disease).
    Blackett PR
    Ann Clin Lab Sci; 1982; 12(5):424-30. PubMed ID: 6753728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carbohydrates in the treatment of glycogenoses].
    Hayde M; Widhalm K
    Infusionstherapie; 1990 Apr; 17(2):69-72. PubMed ID: 2113038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII.
    Mineo I; Kono N; Hara N; Shimizu T; Yamada Y; Kawachi M; Kiyokawa H; Wang YL; Tarui S
    N Engl J Med; 1987 Jul; 317(2):75-80. PubMed ID: 3473284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary hyperuricemia in glycogen storage disease types I, III, V and VII].
    Yamasaki T; Mineo I
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():307-12. PubMed ID: 12629737
    [No Abstract]   [Full Text] [Related]  

  • 14. Three consecutive pregnancies in a patient with glycogen storage disease type IA (von Gierke's disease).
    Ryan IP; Havel RJ; Laros RK
    Am J Obstet Gynecol; 1994 Jun; 170(6):1687-90; discussion 1690-1. PubMed ID: 8203427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of proximal renal tubular dysfunction in type I glycogen storage disease with dietary therapy.
    Chen YT; Scheinman JI; Park HK; Coleman RA; Roe CR
    N Engl J Med; 1990 Aug; 323(9):590-3. PubMed ID: 2199830
    [No Abstract]   [Full Text] [Related]  

  • 16. Dietary management of Type I glycogen storage disease.
    Folk CC; Greene HL
    J Am Diet Assoc; 1984 Mar; 84(3):293-8, 301. PubMed ID: 6583274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of purine biosynthesis in normal and pathologic states.
    Holmes EW; Kelley WN; Wyngaarden JB
    Bull Rheum Dis; 1975-1976; 26(4):848-53. PubMed ID: 1061631
    [No Abstract]   [Full Text] [Related]  

  • 18. Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescence.
    Däublin G; Schwahn B; Wendel U
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S40-5. PubMed ID: 12373569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperuricemia in childhood.
    Howell RR
    Fed Proc; 1968; 27(4):1078-82. PubMed ID: 4232132
    [No Abstract]   [Full Text] [Related]  

  • 20. Pregnancies in glycogen storage disease type Ia.
    Martens DH; Rake JP; Schwarz M; Ullrich K; Weinstein DA; Merkel M; Sauer PJ; Smit GP
    Am J Obstet Gynecol; 2008 Jun; 198(6):646.e1-7. PubMed ID: 18241814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.